1921
Volume 71, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Leptospirosis has recently been described to cause concomitant infection with malaria. Only doxycycline has proven to have chemoprophylactic and therapeutic efficacy for both malaria and leptospirosis. To assess whether other traditional antimalarial agents have antileptospiral activity, we performed broth microdilution susceptibility testing of 16 serovars (6 species/14 serogroups) to various agents. Artemisinin, atovaquone, chloroquine, mefloquine, primaquine, proguanil, pyrimethamine, sulfadoxine, quinine, quinidine, and combinations of atovaquone/proguanil and pyrimethamine/sulfadoxine all had a 90% minimum inhibitory concentration (MIC) > 25 μg/mL (the upper limit of testing). The only agents identified with the potential to treat both infections other than doxycycline (MIC = 1.56 μg/mL) were azithromycin (MIC = 0.002 μg/mL) and clindamycin (MIC = 0.2 μg/mL).

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2004.71.685
2004-11-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/71/5/0700685.html?itemId=/content/journals/10.4269/ajtmh.2004.71.685&mimeType=html&fmt=ahah

References

  1. Wongsrichanalai C, Murray CK, Gray M, Miller RS, McDaniel P, Liao WJ, Pickard AL, Magill AJ, 2003. Co-infection with malaria and leptospirosis. Am J Trop Med Hyg 68 : 583–585.
  2. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3 : 757–771.
  3. Levett PN, 2001. Leptospirosis. Clin Microbiol Rev 14 : 296–326.
  4. Hospenthal DR, Murray CK, 2003. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob Agents Chemother 47 : 2646–2648.
  5. Murray CK, Hospenthal DR, 2004. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob Agents Chemother 48 : 1548–1552.
  6. National Committee for Clinical Laboratory Standards (NC-CLS), 1997. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Fourth Edition. Approved Standard. NCCLS document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards.
  7. Lell B, Kremsner PG, 2002. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 46 : 2315–2320.
  8. Krudsood S, Buchachart K, Chalermrut K, Charusabba C, Treeprasertsuk S, Haoharn O, Duangdee C, Looareesuwan S, 2002. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug falciparum malaria. Southeast Asian J Trop Med Public Health 33 : 525–531.
  9. Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, Braitman D, Murphy GS, Widjaja H, Tjitra E, Ganjar A, Jones TR, Basri H, Berman J, 1999. Malaria prophylaxis using azithromycin: a double-blind, placebo controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 28 : 74–81.
  10. Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS, 2003. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol 41 : 803–809.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2004.71.685
Loading
/content/journals/10.4269/ajtmh.2004.71.685
Loading

Data & Media loading...

  • Received : 10 Apr 2004
  • Accepted : 05 May 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error